comprehensive -WSS

comprehensive

author：explore 2025-08-11 09:47:42 - browse：4

Bob Kocher, a partner at venture capital firm Venrock, speaking at STAT's Breakthrough Summit in San Francisco. Sarah Gonzalez for STAT

SAN FRANCISCO — Health tech investor Bob Kocher has seen some bad AI-related startup pitches in his time. The worst typically involve AI chatbots masquerading as romantic partners to improve people’s mental health.

“They pitch it to me as a mental health improvement model,” Kocher, a partner at venture capital firm Venrock, said. “If you’re sad, anxious, or depressed, why bother with people?”

Kocher, who is also a doctor and helped write the Affordable Care Act as an Obama administration health official, shared his thoughts on the biggest questions facing digital health at STAT’s Breakthrough Summit on Thursday. Besides sharing a peek inside his generative AI pitch-filled inbox, Kocher talked about cybersecurity vulnerabilities in health systems and venture capitalists buying hospitals.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： State Dept. review finds Biden bears some blame for Afghanistan failures
Next article： Eli Lilly to pay $200M for Beam’s stake in gene

focus

hotspot

WSS

Eli Lilly to pay $200M for Beam’s stake in gene

Readout Newsletter: The latest from Bristol, Sarepta, and Novartis

Telehealth options flood the market as retailers push virtual care

The high personal cost of affirmative action for Black doctors

No plane should take off without an EpiPen onboard

The high personal cost of affirmative action for Black doctors

leisure time

comprehensive

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

knowledge

Anesthesiologist group: stop taking Ozempic before surgery

EQRx, failed developer of low

Hollywood unions extend contract negotiations for actors

Physician subsidies by hospitals soar in wake of No Surprises Act

Medicare details structure of new drug price negotiation program

Medtronic CEO on promising devices for diabetes, hypertension

Trump demands the U.S. pay no more for drugs than other countries … again

The FDA weighs the risks of candy

State Dept. review finds Biden bears some blame for Afghanistan failures

Eli Lilly to pay $200M for Beam’s stake in gene

leisure time

Cassava reveals details — and problems — with Alzheimer's study

Readout Newsletter: New research from Sanofi, Regeneron, etc.

Adults seen as increasingly susceptible to measles

Sage hopes for a blockbuster in antidepressant now before FDA

Breakthrough Alzheimer’s drugs are inaccessible in rural states

Chimpanzees, like humans and whales, get menopause: Study

knowledge

focus

hotspot

leisure time